Basic company information:
JiuAn Medical stock, the company's full name is Tianjin JiuAn Medical Electronics Co., Ltd, located in Tianjin, was founded in August 22, 1995, engaged in the medical industry, in June 10, 2010 in Shenzhen Stock Exchange listed, the class of securities is the main board of the Shenzhen Stock Exchange A shares, the listing of the stock code is sz002432.
Online issue date is June 31, 2010, the issue price is 19.38 yuan per share. p>Online issue date is May 31, 2010, the issue of par value of 1.00 yuan per share, the issue price of 19.38 yuan per share, a total of *** issue of 31 million shares, the issue of the market value of up to a total market value of 601 million yuan, the issue of the P/E ratio of 62.52 times, the net funds raised to 569 million yuan. 2010 June 10 officially listed on the market on the first day of the opening price of 29.90 yuan, closed at 29.90 yuan, the first day of the opening price of 29.90 yuan, the closing price of 29.90 yuan, the opening price of 29.90 yuan, the closing price of 29.90 yuan. The closing price was 29.90 yuan, up to 29.99 yuan, and the turnover rate was 29.90%.
The company's business scope: the company is mainly engaged in the research and development, production and sales of home medical equipment, with technical advantages, talent advantages and brand advantages, the annual sales volume of electronic blood pressure monitors in the world's top, is a personal health management products at home and abroad has influence on the supplier. Focusing on the medium and long-term strategic objectives, the company is committed to building a domestic first-class mobile medical service high-tech enterprises, formulated and implemented the "wearable devices and smart hardware as the entrance to enter the field of mobile medical care and health big data, and then around the user to establish a health ecosystem" strategy.
Company Highlights:
Company Advantage: Since its inception, the company has always focused on the construction and improvement of the R & D system, and in recent years has been increasing investment in R & D, has built a strong R & D and design capabilities of the team. The company carries out the strategy of both software and hardware R & D, with 12 laboratories, such as the basic technology development laboratory of blood pressure products, blood glucose basic technology research and development laboratory, and has obtained a number of intellectual property rights, including 13 software copyrights, 126 patent certificates, 19 invention patents, 23 utility models, in a leading position in the industry. For personal health data management, the company has developed and produced a series of products, which have won various awards at home and abroad, such as the Red Dot Award and the iF Award. iHealth series of products can collect data on blood pressure, electrocardiogram, blood sugar, biochemistry and other physiological indexes, thus laying the foundation for big health data. The company has established cloud development teams in both the U.S. and China to utilize new development technologies and build cloud architectures that meet local security standards for services.
In 2020, the company's ROE: 13.65%, ROA: 10.77%, gross margin of 56.31%, net margin of 11.79%; earnings per share of $0.5600.
In the second quarter of 2021, the company's net income is $16.74 million, up -92.09% year-on-year; fully diluted ROA: 0.77%, gross margin: 34.83%, and earnings per share: $0.0361.
Oct 11 11:30:00 Jiu'an Medical latest price of 6.88 yuan, up 1.03%, the turnover rate of 0.21%, the circulating market capitalization of 3.293 billion.